Glycopyrrolate
- Product NDC
- 0143-9682
- 11-digit product format
- 001439682
- Labeler code
- 0143
- Product ID
- 0143-9682_8ed339c6-d65f-4b1c-8e23-301f75258c2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA090963
- Marketing category
- ANDA
- Marketing start
- 2011-09-21
- Substance
- GLYCOPYRROLATE
- Active strength
- .2 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glycopyrrolate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCOPYRROLATE | .2 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | V92SO9WP2I |
| Rxcui | 238212, 1731582, 1731590 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 138c3de2-4b03-4255-92b5-f022482d81bc | Product name | 4 | 20260113 |
| 4dc252b1-bb5f-8bb6-4fa8-f3a45efd810e | Product name | 5 | 20250304 |
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 76dcac30-469f-4f92-9c55-70950d209446 | Product name | 1 | 20230809 |
| 132196a6-5117-4b6e-a9dd-27f2793580c6 | Product name | 1 | 20230112 |
| ac1f888b-a1db-4d2e-abbc-973f21c2ce1b | Product name | 1 | 20220720 |
| d84dd569-7bf0-1410-25eb-017ef37dd406 | Product name | 9 | 20210902 |
| 7d8c8d5a-f174-4e6b-97b1-6fd615c5df9a | Product name | 1 | 20210204 |
| 58b12de9-b891-41c7-9be6-ff47de5ec28b | Product name | 1 | 20180828 |
| 9aff7b10-8e47-4b10-9a92-803440a37ce2 | Product name | 1 | 20180206 |
| ce066c73-ca6f-49fc-83d4-d3cf6728e8a1 | Product name | 1 | 20160616 |
| fb29b8a9-c2d0-42bb-aea8-9bc2a87db75a | Product name | 1 | 20151113 |
| ab7ba50c-5a47-47e6-8dd6-fa32a52559f6 | Product name | 1 | 20151109 |
| 29ae08d1-069f-9822-4820-152d5dc67797 | Product name | 1 | 20140508 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9682-01 | Glycopyrrolate | 1 mL in 1 VIAL | INJECTION | 1 | 6 | |
| 0143-9682-25 | Glycopyrrolate | 25 in 1 CARTON | INJECTION | 25 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9682-01 | ML - Milliliter | 0143-9682 | b00d3e57-bba5-4ffd-b8c0-e59298a4cdb9 | 1 | 2013-09-04 |
| 0143-9682-25 | ML - Milliliter | 0143-9682 | 8f2ace03-ca90-4bfc-a8ad-28a026e1598a | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| GLYCOPYRRONIUM | ACTIVE MOIETY | A14FB57V1D | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 | |
| GLYCOPYRRONIUM | ACTIVE MOIETY | A14FB57V1D | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1731582 | glycopyrrolate 0.2 MG in 1 ML Injection | PSN | 9be0ad4e-3efa-1a24-e053-2995a90a60d5 | 8 |
| 1731582 | 1 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 9be0ad4e-3efa-1a24-e053-2995a90a60d5 | 8 |
| 1731582 | glycopyrrolate 0.2 MG per 1 ML Injection | SY | 9be0ad4e-3efa-1a24-e053-2995a90a60d5 | 8 |
| 1731582 | glycopyrrolate 0.2 MG in 1 ML Injection | PSN | 225d95b4-7f8f-44c2-8fc2-93b75d9cc651 | 7 |
| 1731582 | glycopyrrolate 0.2 MG in 1 ML Injection | PSN | 65688bed-0d70-4b51-8301-1948b1deade1 | 7 |
| 1731582 | 1 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 225d95b4-7f8f-44c2-8fc2-93b75d9cc651 | 7 |
| 1731582 | 1 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 65688bed-0d70-4b51-8301-1948b1deade1 | 7 |
| 1731582 | glycopyrrolate 0.2 MG per 1 ML Injection | SY | 65688bed-0d70-4b51-8301-1948b1deade1 | 7 |
| 1731582 | glycopyrrolate 0.2 MG per 1 ML Injection | SY | 225d95b4-7f8f-44c2-8fc2-93b75d9cc651 | 7 |
| 1731582 | glycopyrrolate 0.2 MG in 1 ML Injection | PSN | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | PSN | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 1731590 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 1731582 | 1 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 1731590 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | SCD | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 1731582 | glycopyrrolate 0.2 MG per 1 ML Injection | SY | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
| 1731590 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0143-9682-01 | 00143968201 | 1 mL in 1 VIAL | 1 ml | Historical | ||||
| 0143-9682-25 | 00143968225 | 25 VIAL in 1 CARTON (0143-9682-25) / 1 mL in 1 VIAL (0143-9682-01) | 25 vial | 2011-09-21 | 0000-00-00 | No | No | Current |